Europe 1 with AFP 4:29 p.m., November 19, 2021
The European Medicines Agency (EMA) said on Friday it had approved emergency use in the European Union of the anti-Covid pill from Merck, which has yet to receive full marketing authorization. Marlet.
The European Medicines Agency (EMA) said on Friday it had approved emergency use in the European Union of the anti-Covid pill from Merck, which has yet to receive full marketing authorization. Marlet.
"The drug, which is currently not authorized in the EU, can be used to treat adults with Covid-19 who do not need supplemental oxygen and who are at increased risk of developing a severe form" of the disease, the EMA said in a statement.
>> More information to follow ...